Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.24.3
Condensed Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash $ 5,822,367 $ 6,989,424
Acquired patents, net 2,682 5,391
Total assets 5,825,049 6,994,815
Current liabilities    
Accounts payable & accrued interest 774,759 256,317
Unreimbursed expenses 67,625 38,089
Total current liabilities 842,384 294,406
Total liabilities 842,384 294,406
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 13,144,653 and 12,848,165 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 13,145 12,848
Additional paid-in capital 63,082,679 57,052,130
Accumulated deficit (58,113,159) (50,364,569)
Total stockholders’ equity 4,982,665 6,700,409
Total liabilities and stockholders’ equity $ 5,825,049 $ 6,994,815